Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02659501 · ClinicalTrials.gov registry record · NA
Liposomal Bupivacaine in Implant Based Breast Reconstruction
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02659501: Clinical Trial NA study, sponsored by Loma Linda University.
NCT02659501 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02659501, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Objectives: 1. To evaluate the effect of liposomal bupivacaine on postoperative pain levels. 2. To evaluate the effect of liposomal bupivacaine on postoperative opioid consumption and opioid related adverse events. 3. To evaluate the effect of liposomal bupivacaine on length of hospital stay. 4. To evaluate the effect of liposomal bupivacaine on patient satisfaction with postoperative pain control. 5. To evaluate the effect of liposomal bupivacaine on overall patient satisfaction.
Primary Outcome
Postoperative pain levels were determined with a numeric rating scale (NRS), rating pain from 0 - 10, where 0 = no pain, 10 = worst possible pain. Higher scores indicate a worse outcome. Pain levels were determined during routine vital signs every 4 hours post-operatively.
Interventions
- DRUG Liposomal bupivacaine
- DRUG Hydrocodone/acetaminophen
- DRUG Diazepam
- DRUG Morphine sulfate
- DRUG Bupivacaine with epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-07 |
| Phase | NA |
Why NCT02659501 stopped before completion
NCT02659501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Liposomal bupivacaine is the first listed.
NCT02659501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02659501 about?
NCT02659501 is a clinical study titled "Liposomal Bupivacaine in Implant Based Breast Reconstruction". Objectives: 1. To evaluate the effect of liposomal bupivacaine on postoperative pain levels. 2. To evaluate the effect of liposomal bupivacaine on postoperative opioid consumption and opioid related adverse events. 3. To evaluate the effect of liposomal bupivacaine on length of hospital stay. 4. To...
What is the current status of trial NCT02659501?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2015-07. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02659501?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Hydrocodone/acetaminophen (DRUG), Diazepam (DRUG), Morphine sulfate (DRUG), Bupivacaine with epinephrine (DRUG).
Who is sponsoring clinical trial NCT02659501?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02659501's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia